Health, Agri-food and Bioeconomy
RBDCOV
The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of two new clinical trials against...
Synthetic and scalable data platform for medical empowered AI
Project dates
2022-2026
Website
Role of Zabala
Partner
Project led by
Fraunhofer Portugal
15
Partners
8
Countries
6 M€
Total budget
4
Years
AISym4Med aims at developing a platform that will provide healthcare data engineers, practitioners, and researchers access to a trustworthy dataset system augmented with controlled data synthesis for experimentation and modeling purposes. This platform will address data privacy and security by combining new anonymization techniques, attribute-based privacy measures, and trustworthy tracking systems.
AISym4Med will help in the creation of more robust machine learning (ML) algorithms for real-world readiness, while considering the most effective computation configuration. Furthermore, a machine learning meta-engine will provide information on the quality of the generalized model by analyzing its limits and breaking points, contributing to the creation of a more robust system by supplying on-demand real and/or synthetic data.
The expected impact, in line with the Strategic Plan, is to contribute to assuring European leadership of breakthrough health technologies and strategic autonomy in essential medical supplies and digital technologies, contributing to job creation and economic growth, in particular with SMEs. Moreover, the identification of needs to the scaleup and take-up of solutions at the national, regional, or local level, respecting European standards, including for operations involving health data. Finally, offering to the Health industry significant improvements in health outcomes, while benefits from decreased time-to-market.
This project has received funding from the European Union’s Horizon Europe research and innovation programme, under grant agreement No. 101095387.
“The project will develop tools that will give a new perspective and vision of how we can help people achieve a better state of health in common diseases.”
Susana Garayoa
Dissemination and Communication Coordinator
Health, Agri-food and Bioeconomy
The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of two new clinical trials against...
Health, Agri-food and Bioeconomy
The main objective of SPIOMET4HEALTH is to test, in a multi-centre Phase II clinical trial, a novel treatment for adolescent...
Industry, Aerospace
AMable provides support for SMEs and mid-cap companies to adopt additive manufacturing solutions.
News
INTERVIEW
Opinion
GLOBAL CHALLENGES
Isabel Carrillo
Senior Consultant
Publication
WATER FUNDING OPPORTUNITIES
Don't miss our publication with European topics and funding opportunities for water-related projects
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
Please enable Strictly Necessary Cookies first so that we can save your preferences!